Smoking is not a protective factor for patients with acute myocardial infarction: The viewpoint of the GISSI-2 study

Giornale Italiano di Cardiologia

Volumn 28, Issue 9, 1998, Pages 970-978

  Maggioni, Aldo Pietro ^a   Piantadosi, Franco ^b   Tognoni, Gianni ^c   Santoro, Eugenio ^c   Franzosi, Maria Grazia ^c  

^a ANMCO RESEARCH CENTER   (Italy)

^b CARDARELLI HOSPITAL   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Acute myocardial infarction; Epidemiology; Smoke

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; HEPARIN; STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CIGARETTE SMOKING; CLINICAL TRIAL; CORONARY ARTERY DISEASE; FEMALE; FIBRINOLYTIC THERAPY; HEART LEFT VENTRICLE FUNCTION; HEART REINFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; STROKE; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; AGED; DATABASES, FACTUAL; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERFUSION; RECURRENCE; RISK ASSESSMENT; SMOKING; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0031657642     PISSN: 00465968     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. RIVERS JT, WHITE JD, CROSS DB, WILLIAMS BF, NORRIS RM: Reinfarction after thrombolysis therapy for acute myocardial infarction followed by conservative management: incidence and effect of smoking. J Am Coll Cardiol 1990; 16: 340-348.
2. JAFRI SM, TILLEY BC, PETERS R, SCHULTZ LR, GOLDSTEIN S: Effects of cigarette smoking and propranolol in survivors of acute myocardial infarction. J Am Coll Cardiol 1990; 65: 271-276.
3. KANNEL WB: Update on the role of cigarette smoking in coronary artery disease. Am Heart J 1981; 101: 319-328.
4. PARISH S, COLLINS R, PETO R, ET AL: Cigarette smoking, tar yields, and non-fatal myocardial infarction: 14 000 cases and 32 000 controls in the United Kingdom. Br Med J 1995; 311: 471-477.
5. NJøLSTAD I, ARNESEN E, LUND-LARSEN PG: Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark study. Circulation 1996; 93: 450-456.
6. ROBINSON K, CONROY RM, MULCAHY R: Smoking and acute coronary heart disease: a comparative study. Br Heart J 1988; 60: 465-469.
7. BARBASH GI, WHITE HD, MODAN M, ET AL: Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Circulation 1993; 87: 53-58.
8. MUELLER HS, COHEN LS, BRAUNWALD E, ET AL: Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the thrombolysis in myocardial infarction (TIMI) trial, phase II. Circulation 1992; 85: 1254-1264.
9. GOMEZ MA, KARAGOUNIS LA, ALLEN A, ANDERSON JL: Effect of cigarette smoking on coronary patency after thrombolytic therapy for myocardial infarction. Am J Cardiol 1993; 72: 373-378.
10. GRINES CL, TOPOL EJ, O'NEILL WW, ET AL: Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation 1995; 91: 298-303.
11. SAHGER D, CERCEK B, CANNON CP, ET AL: How do smokers differ from nonsmokers in their response to thrombolysis? (The TIMI-4 trial). Am J Cardiol 1995; 75: 232-236.
12. DE CHILLOU C, RIFF P, SADOUL N, ET AL: Influence of cigarette smoking on rate of reopening of the infarct-related coronary artery after myocardial infarction: a multivariate analysis. J Am Coll Cardiol 1996; 27: 1662-1668.
13. BARBASH GI, REINER J, WHITE HD, ET AL: Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-1 trial, with angiographic insights. J Am Coll Cardiol 1995; 26: 1222-1229.
14. GRUPPO ITALIANO PER LO STUDIO DELLA SOPRAWIVENZA NELL'INFARTO MIOCARDICO: GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction. Lancet 1990; 336: 65-71.
15. GISSI-2 AND INTERNATIONAL STUDY GROUP: Six-month survival in 20 891 patients with acute myocardial infarction randomized between alteplase and streptokinase with or without heparin. Eur Heart J 1992; 13: 1692-1697.
16. WAGNER GS, FREYE CJ, PALMIERI ST, ET AL: Evaluation of a QRS scoring system for estimating myocardial infarct size. Specificity and observer agreement. Circulation 1982; 65: 342-347.
17. BOSSAERT L, CONRAADS V, PINTENS H, AND THE BELGIAN EMS STUDY GROUP: ST-segment analysis: a useful marker for reperfusion after thrombolysis with APSAC? Eur Heart J 1991; 12: 357-362.
18. MAURI F, MAGGIONI AP, FRANZOSI MG, SANTORO E, TOGNONI G: A simple ECG predictor of the outcome of patients with AMI treated with a thrombolytic agent: a GISSI-2 derived analysis. Circulation 1992; 86: 1-134.
19. DE VITA C, FRANZOSI MG, GERACI E, ET AL: GISSI-2: mortality plus extensive left-ventricular damage as "end-point". Lancet 1990; 335: 289-290.
20. FOLLAND ED, PARISI AF, MOYNIHAN PF, JONES DR, FELDMAN CL, Tow DE: Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography. A comparison of cineangiographic and radionuclide techniques. Circulation 1972; 60: 760-766.
21. SCHLESSELMAN JJ, STOLLEY PD: Basic methods of analysis. In: Case-control studies. Design, conduct, analysis. New York, Oxford University Press, 1982; 171-226.
22. SCHLESSELMAN JJ, STOLLEY PD: Multivariate analysis. In: Case-control studies. Design, conduct, analysis. New York, Oxford University Press, 1982; 227-290.
23. SCHOR S, SHANI M, MODAN B: Factors affecting immediate mortality of patients with acute myocardial infarction: a nationwide study. Chest 1975; 68: 217-221.
24. SPARROW D, DAWBER TR, COLTON T: The influence of cigarette smoking on prognosis after a first myocardial infarction. J Chronic Dis 1978; 31: 425-432.
25. MAURI F, GASPARINI M, BARBONAGLIA L, ET AL: Prognostic significance of the extend of myocardial injury in acute myocardial infarction treated by streptokinase (the GISSI Trial). Am J Cardiol 1989; 63: 1291-1295.
26. KELLY TL, GILPIN E, AHNVE S, HENNING H, Ross J JR: Smoking status at the time of acute myocardial infarction and subsequent prognosis. Am Heart J 1985; 110: 535-541.
27. MAGGIONI AP, FRANZOSI MG, SANTORO E, WHITE H, VAN DE WERF F, TOGNONI G: The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. N Engl J Med 1992; 327: 1-6.
28. MOLSTAD P: First myocardial infarction in smokers. Eur Heart J 1991; 12: 753-759.